Zhejiang Jianfeng Group: Announcement of Progress in Zhejiang Jianfeng Group's Major Transaction Planning with Tasly Pharmaceutical Group, a subsidiary of Biomedical Industry Group Co., Ltd.
Announcement of the resolution of the 3rd meeting of the 12th board of directors of Zhejiang Jianfeng Group.
Announcement of Jianfeng Group on holding the 2023 Annual Results Briefing
Independent Director's 2023 Debriefing Report (Fu Qi)
Jianfeng Group 2023 Internal Control Audit Report
Independent Director's 2023 Debriefing Report (Huang Congyun)
Independent Director's 2023 Debriefing Report (Yang Dalong)
Announcement of Resolutions of the 2nd Meeting of the 12th Board of Directors of Jianfeng Group
Announcement of Jianfeng Group on providing guarantees for holding subsidiaries
Jianfeng Group 2023 Audit Report
Independent Director's 2023 Debriefing Report (Shen Weiguo)
Special opinion of the board of directors of Jianfeng Group on evaluating the independence of serving independent directors
Jianfeng Group's 2023 Performance Assessment Report on Accounting Firms
Announcement of Resolutions of the 2nd Meeting of the 11th Board of Supervisors of Jianfeng Group
Announcement of Jianfeng Group on the company's main operating data for the first quarter of 2024
Jianfeng Group's announcement on the change of accounting firms
Announcement of Resolutions of the 1st Board of Directors of the 12th Jianfeng Group
“Jianfeng Group Fund Management System”
“Jianfeng Group Internal Audit Management System”
Announcement of Resolutions of the 1st Board of Supervisors of the 11th Jianfeng Group
No Data